Clinical Trials on Clinical Oncology in Czechia

Total 26 results

Nutricia Research

Recruiting

Effect of Omega 3 Enriched Oral Nutritional Supplement on Nutritional Status of CRC and NSCLC Patients (OMENS)

Malnutrition | Oncology

Ireland, Belgium, Czechia
St. Anne's University Hospital Brno, Czech Republic
Palacky University

Terminated

Pharmacokinetics of Colistin in Critically Ill Patients With Extracorporeal Membrane Oxygenation (COL-ECMO2022)

Colistin

Czechia
Charles University, Czech Republic
Faculty Hospital Kralovske Vinohrady

Recruiting

Skeletal Muscle Regeneration in Survivors of Critical Illness: How to Prevent Satellite Cell Failure? (SATELLITE)

Intensive Care Unit-acquired Weakness

Czechia
Institute for Clinical and Experimental Medicine

Recruiting

Continuous Glucose Monitoring in Intensive Care Unit

Blood Glucose | Critical Care

Czechia
Charles University, Czech Republic
Faculty Hospital Kralovske Vinohrady

Unknown

Early Mobilization and Intensive Rehabilitation in the Critically Ill (EMIR)

Critical Illness

Czechia
Masaryk University
Brno University Hospital

Completed

Muscle Mass Loss in Critically Ill Patients. (MUSIC)

Muscle Loss

Czechia
University Hospital Hradec Kralove

Completed

Glycocalyx Damage and Beta-lactam Antibiotics in Surgical Critically Ill

Critical Illness

Czechia
University Hospital Hradec Kralove

Completed

Glycocalyx Damage in Critically Ill Patients

Critical Illness

Czechia
Brno University Hospital

Not yet recruiting

The Influence of Blood Sampling Technique on the Total Amount of Blood Collected for Laboratory Testing Critically Ill Pediatric Patients (PEDPBM)

Iatrogenic Anaemia

Czechia
The Institute of Molecular and Translational Medicine...

Not yet recruiting

Exhaled Breath Condensate Analysis in Mechanically Ventilated Patients

Critical Illness | Acute Respiratory Failure

Czechia
Cook Group Incorporated

Completed

Pilot Safety Study of Injectable SIS for Critical Limb Ischemia (CLIC)

Peripheral Arterial Disease | Peripheral Vascular Disease | Critical Limb Ischemia

Czechia
University Hospital Ostrava
Ministry of Health, Czech Republic; Regional Council of the Moravian-Silesian...

Completed

Safety and Efficacy Study of Autologous Bone Marrow Aspirate Concentrate for No-Option Critical Limb Ischemia (DIALEG)

Critical Lower Limb Ischemia | Type-2 Diabetes Mellitus

Czechia
University Hospital Ostrava

Completed

Prevention of Nicotine Abstinence in Critically Ill Patients After Major Surgery

Nicotine Dependence

Czechia
Karolinska University Hospital

Not yet recruiting

Metabolic Pathway Analysis in Intensive Care Unit Patients With Refeeding Syndrome

Critical Illness | Hypophosphatemia | Refeeding Syndrome

Sweden, Czechia, Italy
Amgen

Completed

Observational Study of Blinatumomab

Blincyto Use in Routine Clinical Practice

Netherlands, France, Czechia, Sweden, Austria, Italy, Switzerland, Germany, Finland, United Kingdom, Portugal, Greece, Poland
ASQA a.s.

Unknown

Lithium Dilution Method in Guiding Fluid Therapy in Critically Ill Patients (LIGA)

Critical Illness

Czech Republic
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...
Charles University, Czech Republic

Unknown

Determination of the Dissociation Constant (Ka) of Plasma and Whole Blood in Septic Patients (ENTERPRISE)

Sepsis | Critical Illness | Septic Shock | Acid-Base Imbalance | Respiratory Acidosis | Respiratory Alkalosis

Italy, Czechia
Charles University, Czech Republic
Ministry of Health, Czech Republic

Unknown

Metabolic Aspects of Citrate Anticoagulation in Renal Replacement Therapy (Citrate)

Critical Illness | Acute Renal Failure

Czech Republic
Pluristem Ltd.

Unknown

Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization

Critical Limb Ischemia (CLI)

Germany, United Kingdom, Hungary, United States, Bulgaria, Czechia, Israel, North Macedonia, Poland
Fresenius Kabi
IQVIA Commercial GmbH & Co. OHG

Completed

Observational Cohort Study on the Use of Parenteral Nutrition and Clinical Outcomes in Adult Critically Ill Patients

Critical Illness

France, Austria, Spain, Belgium, Germany, Hungary, United Kingdom, Poland, Italy, Czechia, Sweden
NantCell, Inc.
Takeda

Terminated

QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas (GAMMA)

Cancer | Pancreatic Cancer | Advanced Solid Tumors | Metastatic Cancer | Bone Metastases | Solid Tumors | Pancreas Cancer | Adenocarcinoma of the Pancreas | Oncology | Cancer of Pancreas | Metastatic Pancreatic Cancer | Metastases | Cancer of the Pancreas | Advanced Malignancy | Oncology Patients | Endocrine Cancer

Italy, Spain, United Kingdom, Belgium, Canada, Denmark, Romania, United States, Germany, Netherlands, Korea, Republic of, Russian Federation, Australia, Austria, Lithuania, Portugal, Greece, Poland, Switzerland, Serbia, Bulgaria, ... and more
Biogen

Completed

Tolerability and Quality of Life Study in Participants Who Switched to Avonex Pen (SFERA)

Multiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Clinical Isolated Syndrome (CIS)

Czech Republic, Switzerland
Ixaka Ltd
Andalusian Network for Design and Translation of Advanced Therapies

Terminated

The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM

Cardiovascular Disease | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Critical Limb Ischemia (CLI) | Peripheral Arterial Disease (PAD) | Diabetes Mellitus (DM)

Spain, Czechia, Portugal, Hungary, Germany, Poland
Ixaka Ltd
Andalusian Network for Design and Translation of Advanced Therapies

Terminated

The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM

Cardiovascular Disease | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Critical Limb Ischemia (CLI) | Peripheral Arterial Disease (PAD) | Diabetes Mellitus (DM)

Spain, Netherlands, United Kingdom, Czechia, Portugal, Hungary
Merck KGaA, Darmstadt, Germany

Completed

Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX) (REFLEXION)

Multiple Sclerosis | Clinically Isolated Syndrome

Croatia, Bulgaria, France, Italy, Russian Federation, Spain, Estonia, Germany, Latvia, Poland, Romania, Argentina, Finland, Israel, Greece, Czech Republic, Slovakia, Austria, Belgium, Canada, Lebanon, Morocco, Portugal, Serbia
Amgen
Daiichi Sankyo, Inc.

Completed

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma

Cancer | Multiple Myeloma | Bone Metastases | Hematologic Malignancies | Oncology | Multiple Myeloma Bone Lesions

United States, Germany, Italy, Spain, Canada, France, Czechia, Hungary, Korea, Republic of, Russian Federation, United Kingdom, Taiwan, Australia, Hong Kong, New Zealand, Austria, Slovakia, Portugal, Greece, Bulgaria, Poland, Ukraine and more

Clinical Trials on Clinical Oncology in Czechia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations